Pacific Biosciences Closes Acquisition of Omniome and Establishes San Diego Presence
Omniome’s high accuracy short-read sequencing platform expected to significantly expand PacBio’s market opportunity Acquisition expected to accelerate the adoption of SMRT Sequencing, PacBio’s leading long-read sequencing platform PacBio also closes $300 million PIPE financing in support of transaction MENLO PARK, Calif., Sept. 20, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq: PACB)(“Pacific Biosciences” or “PacBio”),... Read more